Home >> Report Store >> Healthcare >> Fondaparinux Market Size, Share & Industry Report, 2025 >

Fondaparinux Market Size Worth USD 580.6 Million by 2025 | CAGR: 6.4%

Published Date : July 2019 | Report Code: AV333 | Report Format: PDF

The global fondaparinux market is expected to grow at CAGR of 6.4% to reach USD 580.6 billion by 2025.

Fondaparinux is a synthetic anticoagulant, chemically related to the low molecular weight polymeric glycosaminoglycan heparins. The drug is majorly indicated to prevent venous thromboembolism, deep vein thrombosis, pulmonary embolism, unstable angina and in management of myocardial infarction. The drug’s associated benefits such as fast onset, high bioavailability, less adverse reactions and long half-life will make it to replace the potential anticoagulant drug, heparin. Conditions such as cerebral infarction, myocardial infarction, and atrial fibrillation are related to thrombosis and require antithrombotic such as fondaparinux.

In addition, increasing cardiovascular disease cases will stimulate the product demand. As per the World Health Organization (WHO), cardiovascular disease is the biggest killer claiming nearly 17.9 million death globally in 2016. One of the factors that will also drive the market growth is the increase in the number of hip and knee surgeries. Organisation for Economic Co-operation and Development (OECD) Health Statistics 2017 stated that on an average the cases of hip replacement increased 30% from the year 2000 to 2015. Anticoagulants are also provided to geriatric populations due to a number of complications that could arise due to age-related diseases, supporting the industry growth. However, high cost of this drug thwarts its extensive usage globally. One of the major reasons for its high price is complex manufacturing process the drug has to go through.

Key Takeaways

  • Types segment is divided into branded and generics. Generic category captures significant revenue and is available as injectable blood thinner, popularly known as Arixtra.
  • From an application perspective generally the drug is used in hospitals, clinics, ambulances, home care set ups and diagnostic facilities across the healthcare set up.
  • An increase in the number of cancer and cardiovascular patients in North America is considered to be one of the reasons why this region has the leading users of the drug Fondaparinux
  • Countries such as France, Japan, and Spain have adopted policies that promote the use of these generic drugs as there is better control over the pricing for these as compared to branded products
  • Manufacturers covered under the report scope are Alchemia Ltd., GlaxoSmithKline Plc, Dr. Reddy’s Laboratories, Abbott Laboratories, Inc., ScinoPharm Taiwan Ltd., Apotex, Inc., Lupin Pharmaceuticals and Aurobindo Pharma
  • Companies are engaged in new product introduction and merger & acquisitions to attract large customer base in this consolidated industry. Recently, in December 2017, Aurobindo Pharma received US FDA approval of Fondaparinux Sodium injection


  • The report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
  • A thorough analysis of relevant statistical data to estimate the market paradigms
  • Exceptional understanding of region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts, and growth specific to the countries.
  • Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation


  • Branded
  • Generic


  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Home Care Settings
  • Clinics
  • Hospitals


  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of APAC
  • Rest of the World
    • Middle East and Africa
    • Latin America

Why AnalystView?


Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.


Tailor-Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.


Data Accuracy and Reliability

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials

Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us

We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience something similar.

Share This